Anti-IL-18 (Mouse) mAb

Western Blotting

1. Hoshino T et al. Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. J Immunol. 166, 7014-8 (2001)(PMID:11390444)
2. Seino H et al. IL-18 mediates the formation of stress-induced, histamine-dependent gastric lesions. Am J Physiol Gastrointest Liver Physiol. 292, G262-7 (2007)(PMID:16959946)
3. Hoshino T et al. Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Am J Respir Crit Care Med. 176, 49-62 (2007)(PMID:17400729)
4. Venkatachalam K et al. Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury. J Biol Chem. 284,
   7853-65 (2009) (PMID:19164288)
5. Fujiwara H et al. Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun. 9, 3674 (2018)(PMID:30201970)
6. Yamanishi K et al. Deficiency in interleukin-18 promotes differentiation of brown adipose tissue resulting in fat accumulation despite dyslipidemia. J Transl Med. 16, 314 (2018)(PMID:30453990)
7. Chakravarti D et al. Telomere dysfunction activates YAP1 to drive tissue inflammation.Nat Commun. 11, 4766 (2020) (PMID:32958778)
8. Ambati J et al. Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development. Nat Commun. 11, 4737 (2020)(PMID:32968070)

Neutralization

1. Lertmemongkolchai G et al. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J. Immunol. 166, 1097-105 (2001)(PMID:11145690)